Lack of effect of a topical regenerative agent on re-epithelialization rate of canine spontaneous chronic corneal epithelial defects: A randomized, double-masked, placebo-controlled study.

[1]  A. Rosa,et al.  Neurotrophic Keratopathy: Therapeutic Approach Using a Novel Matrix Regenerating Agent. , 2017, Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics.

[2]  D. Papy-Garcia,et al.  RGTA® or ReGeneraTing Agents mimic heparan sulfate in regenerative medicine: from concept to curing patients , 2016, Glycoconjugate Journal.

[3]  N. Lagali,et al.  RGTA in corneal wound healing after transepithelial laser ablation in a rabbit model: a randomized, blinded, placebo‐controlled study , 2016, Acta ophthalmologica.

[4]  J. Holopainen,et al.  Matrix Regeneration Therapy: A Case Series of Corneal Neurotrophic Ulcers , 2016, Cornea.

[5]  Joanna C Norman,et al.  Effect of corneal contact lens wear on healing time and comfort post LGK for treatment of SCCEDs in boxers. , 2015, Veterinary ophthalmology.

[6]  I. Aslanides,et al.  A pharmacological modification of pain and epithelial healing in contemporary transepithelial all-surface laser ablation (ASLA) , 2015, Clinical ophthalmology.

[7]  M. Tsilimbaris,et al.  Combined Topical Application of a Regenerative Agent With a Bandage Contact Lens for the Treatment of Persistent Epithelial Defects , 2014, Cornea.

[8]  J. Warnet,et al.  RGTA-based matrix therapy in severe experimental corneal lesions: safety and efficacy studies. , 2013, Journal francais d'ophtalmologie.

[9]  Allyson A. Gosling,et al.  Management of spontaneous chronic corneal epithelial defects (SCCEDs) in dogs with diamond burr debridement and placement of a bandage contact lens. , 2013, Veterinary ophthalmology.

[10]  A. Delcampe,et al.  Topical treatment with a new matrix therapy agent (RGTA) for the treatment of corneal neurotrophic ulcers. , 2012, Investigative ophthalmology & visual science.

[11]  C. Baudouin,et al.  Étude pilote d’un nouvel agent de thérapie matricielle (RGTA OTR4120 ® ) dans les ulcères de cornée et les dystrophies cornéennes rebelles , 2008 .

[12]  E. Bentley.  Spontaneous chronic corneal epithelial defects in dogs: a review. , 2005, Journal of the American Animal Hospital Association.

[13]  C. Hardman,et al.  Results of grid keratotomy, superficial keratectomy and debridement for the management of persistent corneal erosions in 92 dogs. , 1998, Veterinary ophthalmology.